Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31141158 | 0.86 | THRB (0.46) | THRBALDH1A1HTTNPSR1CHRNB2 | |
| SCHEMBL30706809 | 0.80 | GLA (0.37) | ALDH1A1HTTNPSR1CHRNB2CHRNA4 | |
| SCHEMBL30125489 | 0.79 | ARG1 (0.31) | ALDH1A1HTTNPSR1 | |
| SCHEMBL25041122 | 0.77 | ALDH1A1 (0.33) | ALDH1A1HTT | |
| SCHEMBL31043942 | 0.77 | MEN1 (0.35) | ALDH1A1HTTNPSR1LMNAKMT2A | |
| Hydrochloric Acid SCHEMBL30889338 | 0.76 | ALDH1A1 (0.32) | ALDH1A1HTT | |
| SCHEMBL10206074 | 0.76 | THRB (0.44) | THRBALDH1A1HTTNPSR1LMNA | |
| SCHEMBL22653530 | 0.75 | — | — | |
| SCHEMBL31141117 | 0.72 | THRB (0.37) | THRB | |
| SCHEMBL2841738 | 0.72 | THRB (0.63) | THRBALDH1A1HTTNPSR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119677749-A | Azaquinazoline pan KRAS inhibitors | 米拉蒂治疗股份有限公司 | 2025-03-21 | — | — | CN | disclosed |